NASDAQ:ABOS | Income Statement | Acumen Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$27.81M$32.56M-$32.56M-$162,000.00-$32.72M-$0.45-$0.4572,250,69472,250,694
2026-03-31$16.48M$21.15M-$21.15M$412,000.00-$20.74M-$0.33-$0.3363,219,28963,219,289
2025-12-31$20.53M$25.2M-$25.2M$61,000.00-$25.14M-$0.41-$0.414,1684,168
2025-09-30$21.97M$26.51M-$26.51M$62,000.00-$26.45M-$0.44-$0.4460,573,42560,573,425
2025-06-30$37.13M$41.75M-$41.75M$800,000.00-$40.95M-$0.68-$0.6860,573,42560,573,425
2025-03-31$25.27M$30.37M-$30.37M$1.57M-$28.8M-$0.48-$0.4860,525,62860,525,628
2024-12-31$34.57M$39.6M-$39.6M$2.44M-$37.15M-$0.62-$0.6222,43322,433
2024-09-30$27.25M$32.27M-$32.27M$2.5M-$29.77M-$0.50-$0.5060,079,77860,079,778
2024-06-30$19.53M$24.38M-$24.38M$3.84M-$20.54M-$0.34-$0.3460,079,77860,079,778
2024-03-31$12.45M$17.77M-$17.77M$2.9M-$14.87M-$0.25-$0.2559,812,00059,812,000
2023-12-31$13.29M$18.49M-$18.49M$1.99M-$16.5M-$0.29-$0.293,134,4303,134,430
2023-09-30$11.18M$16.04M-$16.04M$3.08M-$12.96M-$0.24-$0.2454,229,63054,229,630
2023-06-30$9.13M$13.48M-$13.48M$1.87M-$11.61M-$0.28-$0.2841,025,06241,025,062
2023-03-31$8.71M$13.14M-$13.14M$1.83M-$11.31M-$0.28-$0.2841,025,06241,025,062
2022-12-31$10.75M$14.25M-$14.25M$1.38M-$12.87M-$0.32-$0.32110,755110,755
2022-09-30$8.31M$11.37M-$11.37M$661,000.00-$10.71M-$0.26-$0.2640,502,86040,502,860
2022-06-30$7.32M$10.41M-$10.41M$260,000.00-$10.15M-$0.25-$0.2540,497,08740,497,087
2022-03-31$5.99M$9.21M-$9.21M$77,000.00-$9.13M-$0.23-$0.2340,473,27040,473,270
2021-12-31$5.67M$8.42M-$8.42M$66,000.00-$8.35M$1.98$1.986,879,5516,879,551
2021-09-30$1.8M$3.94M-$3.94M$33,000.00-$3.9M-$0.10-$0.1038,266,59338,266,593
2021-06-30$2.25M$3.44M-$3.44M-$57.92M-$61.36M-$141.93-$141.93432,325432,325
2021-03-31$2.58M$3.79M-$3.79M-$23.2M-$27M419,124
2020-12-31$1.03M$1.67M-$1.34M$586,000.00-$755,000.000
2020-09-30$2.99M$3.22M-$2.49M-$2.49M419,124
2020-06-30$1.93M$2.19M-$2.04M-$2.04M419,124

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$104.89M$123.83M-$123.83M$2.5M$0.00-$121.34M-$2.00-$2.0060,561,83660,561,836
2024-12-31$93.8M$114.02M-$114.02M$11.69M$0.00-$102.33M-$1.71-$1.7160,013,27760,013,277
2023-12-31$42.32M$61.14M-$61.14M$8.77M$0.00-$52.37M-$1.08-$1.0848,609,38348,609,383
2022-12-31$32.36M$45.24M-$45.24M$2.38M$0.00-$42.86M-$1.06-$1.0640,601,93640,601,936
2021-12-31$12.31M$19.58M-$19.58M-$81.02M$0.00-$100.61M-$5.02-$5.0220,057,53420,057,534
2020-12-31$8M$9.35M-$7.91M$587,000.00$0.00-$7.33M419,124